Related Experiment Videos
[Continuous ambulatory peritoneal dialysis in Tunisia]
A el Matri1, T Ben Abdallah, C Kechrid
1Service de Médecine interne et de Néphrologie, Hôpital Charles Nicolle, Tunis.
Nephrologie
|January 1, 1990
Summary
Continuous Ambulatory Peritoneal Dialysis (CAPD) is an effective and affordable renal replacement therapy. This study found CAPD to be a viable option for patients in Tunisia, offering good patient outcomes and cost savings compared to hemodialysis.
Area of Science:
- Nephrology
- Public Health
Background:
- Continuous Ambulatory Peritoneal Dialysis (CAPD) represents 4% of renal replacement therapy in Tunisia.
- Patient demographics included variable socio-cultural levels, with a mean age of 36 years.
Purpose of the Study:
- To evaluate the efficacy, complications, and cost-effectiveness of CAPD in Tunisian patients.
- To assess the suitability of CAPD as a renal replacement therapy in developing countries.
Main Methods:
- A cohort of 47 patients (21 males, 26 females) received CAPD between February 1983 and 1988.
- Data collected included patient survival, technique survival, complication rates (peritonitis), and cost analysis compared to hemodialysis.
Main Results:
- Five-year patient survival rate was 46%, with a technique survival rate of 21%.
- Peritonitis was the primary complication (1.8 episodes/patient/year), with a notable incidence of yeast peritonitis.
- CAPD demonstrated a yearly cost approximately one-third lower than center hemodialysis.
Conclusions:
- CAPD is an efficient, valid, and cost-effective renal replacement therapy compared to hemodialysis.
- Good general condition and professional rehabilitation were observed in most patients.
- CAPD is a suitable therapeutic option for Tunisia and other developing countries.